Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |